Search

Search Constraints

You searched for: Author/Creator Leipold, Douglas D.

Search Results

1. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity. (14th November 2019)

2. Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα). Issue 4 (15th February 2020)

3. Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020). (13th January 2020)

4. Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia. Issue 8 (17th November 2018)